Science Explorer Back to mapMap
Discussion
Company · Brisbane · Australia

Leo Pharma (Australia)

In research, Leo Pharma (Australia) stands highest in Health Sciences (#9,988 of 16,688 worldwide) and Medicine (#8,834 of 14,558 worldwide), over all time.

leo-pharma.comROR OpenAlex
World rank, all time
#17,316
of 34,923
Rank in Australia
#280
of 476
Research works
336
▲ 23% vs 2018-21
Citations
7.9k
23.5 per fractional work
Top-10% rate
9.3%
all institutions 10.0%
vs its own fields
0.91×
1.00× is exactly expected
Open access
28%
world 40%
International
51%
world 18%
Leo Pharma (Australia)

What is Leo Pharma (Australia) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #9,988 of 16,688 7.8%135
MedicineField #8,834 of 14,558 7.8%123

Each strip is that field's whole ranked pool, with the notch where Leo Pharma (Australia) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Leo Pharma (Australia) work in?

In 2022-now, 46% of research at Leo Pharma (Australia) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (42%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (7%). It does 1.8× the world's share of Life Sciences.

Health Sciences: 25 fractional works · 46.3% of its workMedicine: 23 fractional works · 41.9% of its workDermatology: 5 fractional works · 9.2% of its workOncology: 4 fractional works · 7.4% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 5.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.1% of its workImmunology and Allergy: 1 fractional works · 1.8% of its workRheumatology: 1 fractional works · 1.7% of its workPhysiology: 1 fractional works · 1.5% of its workPathology and Forensic Medicine: 1 fractional works · 1.4% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.4% of its workEpidemiology: 1 fractional works · 1.3% of its workNephrology: 1 fractional works · 1.1% of its workSurgery: 1 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.0% of its workGeriatrics and Gerontology: 0 fractional works · 0.7% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.6% of its workRehabilitation: 0 fractional works · 0.6% of its workEmergency Medicine: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 2 fractional works · 4.4% of its workGeneral Health Professions: 1 fractional works · 2.5% of its workHealth Information Management: 0 fractional works · 0.8% of its workOccupational Therapy: 0 fractional works · 0.6% of its workSpeech and Hearing: 0 fractional works · 0.3% of its workComplementary and Manual Therapy: 0 fractional works · 0.2% of its workLife Sciences: 16 fractional works · 28.8% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 15.2% of its workMolecular Biology: 5 fractional works · 9.2% of its workCancer Research: 2 fractional works · 3.9% of its workMolecular Medicine: 0 fractional works · 0.5% of its workBiotechnology: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.4% of its workBiophysics: 0 fractional works · 0.3% of its workEndocrinology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workImmunology and Microbiology: 4 fractional works · 6.9% of its workImmunology: 4 fractional works · 6.7% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 4.2% of its workPharmaceutical Science: 1 fractional works · 2.1% of its workPharmacology: 1 fractional works · 1.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 2.2% of its workPlant Science: 0 fractional works · 0.5% of its workForestry: 0 fractional works · 0.4% of its workAnimal Science and Zoology: 0 fractional works · 0.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.3% of its workFood Science: 0 fractional works · 0.2% of its workInsect Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.4% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 7 fractional works · 13.5% of its workSocial Sciences: 3 fractional works · 5.2% of its workSociology and Political Science: 2 fractional works · 3.0% of its workTransportation: 1 fractional works · 1.2% of its workLinguistics and Language: 0 fractional works · 0.3% of its workUrban Studies: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workArts and Humanities: 1 fractional works · 2.6% of its workLiterature and Literary Theory: 1 fractional works · 1.2% of its workPhilosophy: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 1 fractional works · 1.9% of its workManagement of Technology and Innovation: 1 fractional works · 1.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPsychology: 1 fractional works · 1.5% of its workClinical Psychology: 0 fractional works · 0.9% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.6% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.4% of its workEconomics and Econometrics: 1 fractional works · 1.4% of its workDecision Sciences: 0 fractional works · 0.9% of its workInformation Systems and Management: 0 fractional works · 0.9% of its workPhysical Sciences: 6 fractional works · 11.4% of its workEngineering: 2 fractional works · 3.9% of its workAerospace Engineering: 1 fractional works · 1.2% of its workMechanical Engineering: 1 fractional works · 1.2% of its workBiomedical Engineering: 1 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.3% of its workComputer Science: 2 fractional works · 3.2% of its workComputational Theory and Mathematics: 1 fractional works · 1.3% of its workInformation Systems: 1 fractional works · 1.2% of its workSoftware: 0 fractional works · 0.6% of its workMaterials Science: 1 fractional works · 1.6% of its workMaterials Chemistry: 0 fractional works · 0.9% of its workBiomaterials: 0 fractional works · 0.3% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.9% of its workAnalytical Chemistry: 0 fractional works · 0.6% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.8% of its workStatistics and Probability: 0 fractional works · 0.8% of its workEnvironmental Science: 0 fractional works · 0.6% of its workEcology: 0 fractional works · 0.4% of its workPollution: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.3% of its workALL ITS WORKLeo Pharma(Australia)54fractional works, 2022-now
Life Sciences29%Physical Sciences11%Health Sciences46%Social Sciences13%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine2341.9%
    2. Health Professions24.4%
    1. Biochemistry, Genetics and Molecular Biology815.2%
    2. Immunology and Microbiology46.9%
    3. Pharmacology, Toxicology and Pharmaceutics24.2%
    4. Agricultural and Biological Sciences12.2%
    5. Neuroscience00.4%
    1. Social Sciences35.2%
    2. Arts and Humanities12.6%
    3. Business, Management and Accounting11.9%
    4. Psychology11.5%
    5. Economics, Econometrics and Finance11.4%
    6. Decision Sciences00.9%
    1. Engineering23.9%
    2. Computer Science23.2%
    3. Materials Science11.6%
    4. Chemistry00.9%
    5. Mathematics00.8%
    6. Environmental Science00.6%
    7. Physics and Astronomy00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.46× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.85× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 6.84× its world share, 4 worksImmunology and Micro…Neuroscience: 0.24× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 11.85× its world share, 2 worksPharmacology, Toxico…Chemistry: 0.59× its world share, 0 worksChemistryComputer Science: 0.41× its world share, 2 worksComputer ScienceEngineering: 0.26× its world share, 2 worksEngineeringEnvironmental Science: 0.13× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.46× its world share, 1 worksMaterials ScienceMathematics: 0.66× its world share, 0 worksMathematicsPhysics and Astronomy: 0.14× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.67× its world share, 2 worksHealth ProfessionsMedicine: 2.18× its world share, 23 worksMedicineArts and Humanities: 0.89× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.60× its world share, 1 worksBusiness, Management…Decision Sciences: 0.96× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.63× its world share, 1 worksEconomics, Econometr…Psychology: 0.49× its world share, 1 worksPsychologySocial Sciences: 0.41× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.8×. Every wedge is a field page.

All 20 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics11.85×2 works
  2. Immunology and Microbiology6.84×4 works
  3. Biochemistry, Genetics and Molecular Biology2.85×8 works
  4. Medicine2.18×23 works
  5. Health Professions1.67×2 works
  6. Decision Sciences0.96×0 works
  7. Arts and Humanities0.89×1 works
  8. Mathematics0.66×0 works
  9. Economics, Econometrics and Finance0.63×1 works
  10. Business, Management and Accounting0.60×1 works
  11. Chemistry0.59×0 works
  12. Psychology0.49×1 works
  13. Agricultural and Biological Sciences0.46×1 works
  14. Materials Science0.46×1 works
  15. Computer Science0.41×2 works
  16. Social Sciences0.41×3 works
  17. Engineering0.26×2 works
  18. Neuroscience0.24×0 works
  19. Physics and Astronomy0.14×0 works
  20. Environmental Science0.13×0 works

Who are the top researchers at Leo Pharma (Australia)?

Ranked on the quality score, Anne-Marie Hackett, Jiann-Shiun Lai and Ming-Chen Yang lead among researchers whose main affiliation is Leo Pharma (Australia).

  1. 1 Anne-Marie Hackett Australia · #1,392,740 worldwide 150 citations · 37 works
  2. 2 Jiann-Shiun Lai Australia · #2,437,983 worldwide 560 citations · 28 works
  3. 3 Ming-Chen Yang Australia · #2,858,941 worldwide 309 citations · 20 works
  4. 4 Kirsten Bunch‐Christensen Australia · #3,038,023 worldwide 538 citations · 18 works
  5. 5 S. Veige Australia · #3,268,694 worldwide 1.9k citations · 101 works
  6. 6 Guilherme de Souza Cabral Muzy Australia · #4,019,032 worldwide 163 citations · 22 works
  7. 7 Diego Santiago Laguna Australia · #4,762,223 worldwide 1 citations · 21 works
  8. 8 A. P. Menday Australia · #4,832,761 worldwide 294 citations · 24 works
  9. 9 Brandi T. Marsh Australia · #4,911,979 worldwide 294 citations · 28 works
  10. 10 Dmitry D. Petrunin Australia · #5,881,494 worldwide 142 citations · 54 works
All ranked researchers at Leo Pharma (Australia)

What are the most cited papers from Leo Pharma (Australia)?

The most cited paper from Leo Pharma (Australia) is "The role of lipid components in lipid nanoparticles for vaccines and gene therapy" (Camilla Hald Albertsen, Jayesh A. Kulkarni, Dominik Witzigmann et al., 2022), with 1,183 citations. Next come "A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism" (786) and "Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association" (462).

Most cited papers
#PaperReleasedCitations
1 The role of lipid components in lipid nanoparticles for vaccines and gene therapy Camilla Hald Albertsen, Jayesh A. Kulkarni, Dominik Witzigmann et al. · Advanced Drug Delivery Reviews ReviewOpen access 3 Jul 2022 1,183
2 A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism Gérald Simonneau, Hervé Sors, Bernard Charbonnier et al. · New England Journal of Medicine Open access 4 Sep 1997 786
3 Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association Abdulla A. Damluji, Sean van Diepen, Jason Neil Katz et al. · Circulation Open access 15 Jun 2021 462
4 Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure Neveen A T Hamdy, J. A. Kanis, Monique N.C. Beneton et al. · BMJ Open access 11 Feb 1995 323
5 Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers K.O. Fagerström, Michael Kunze, Rudolf Schoberberger et al. · Tobacco Control Open access Mar 1996 314
All 60 most cited papers, with filters and sorting

Which keywords describe research at Leo Pharma (Australia)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Glycosylation, Immune Dysregulation, Chemotherapy, Immune System, Filaggrin, Skin Microbiome, Epidemiology and TGF-ß.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology5▲ 2.1×19 topics
  2. Glycosylation3▲ 54×3 topics
  3. Chemotherapy3▲ 7.8×10 topics
  4. Immune Dysregulation3▲ 71×2 topics
  5. Quality of Life3▲ 3.8×12 topics
  6. Filaggrin3▲ 108×1 topic
  7. Immune System3▲ 23×2 topics
  8. Skin Microbiome3▲ 108×1 topic
  9. Cancer3▲ 3.6×11 topics
  10. TGF-ß2▲ 27×2 topics
  11. Monoclonal Antibodies2▲ 46×2 topics
  12. Regulatory T Cells2▲ 36×2 topics
  13. Therapeutic Antibodies2▲ 59×2 topics
  14. Tumor Microenvironment2▲ 9.0×6 topics
  15. IL-172▲ 109×1 topic
  16. TH17 Cells2▲ 109×1 topic
  17. Antibody Engineering2▲ 69×1 topic
  18. Fc Receptors2▲ 69×1 topic
  19. Monoclonal Antibody2▲ 68×2 topics
  20. Angiogenesis2▲ 10×4 topics
  21. Diagnosis2▲ 3.8×8 topics
  22. Breast Cancer2▲ 13×4 topics
  23. Immune Response2▲ 5.7×5 topics
  24. Metastasis2▲ 9.6×5 topics
  25. Metastatic2▲ 52×2 topics
  26. Treatment2▲ 2.7×10 topics
  27. Cell Differentiation2▲ 35×2 topics
  28. EGFR2▲ 98×1 topic
  29. HER22▲ 98×1 topic
  30. Management2▲ 4.0×6 topics
  31. Trastuzumab2▲ 63×2 topics
  32. Cancer Progression2▲ 16×3 topics
  33. HIF-11▲ 39×1 topic
  34. Smad-dependent pathways1▲ 300×1 topic
  35. Tumor Suppression1▲ 33×1 topic
  36. Warburg Effect1▲ 39×1 topic
  37. Adverse Drug Reactions1▲ 42×3 topics
  38. Cancer Immunotherapy1▲ 15×3 topics
  39. Primary Care1▲ 6.1×4 topics
  40. Autoantibodies1▲ 8.2×4 topics

Which research topics does Leo Pharma (Australia) publish most on?

By volume in 2022-now: Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Monoclonal and Polyclonal Antibodies Research and HER2/EGFR in Cancer Research.

Dermatology and Skin Diseases: 3 fractional worksPsoriasis: Treatment and Pathogenesis: 2 fractional worksMonoclonal and Polyclona…2Monoclonal and Polyclonal Antibodies Research: 2 fractional worksHER2/EGFR in Cancer Rese…2HER2/EGFR in Cancer Research: 2 fractional worksTGF-β signaling in diseases: 1 fractional worksCancer, Hypoxia, and Metabolism: 1 fractional worksInnovative Approaches in…1Innovative Approaches in Technology and Social Development: 1 fractional worksHealthcare Systems and Practices: 1 fractional worksContact Dermatitis and Allergies: 1 fractional worksGlycosylation and Glycoproteins Research: 1 fractional works
DermatologyImmunologyRadiology, Nuclear Medicine and ImagingOncology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Dermatology and Skin Diseases Dermatology 3 works
  2. 2 Psoriasis: Treatment and Pathogenesis Immunology 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 HER2/EGFR in Cancer Research Oncology 2 works
  5. 5 TGF-β signaling in diseases Molecular Biology 1 works
  6. 6 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  7. 7 Innovative Approaches in Technology and Social Development Management of Technology and Innovation 1 works
  8. 8 Healthcare Systems and Practices General Health Professions 1 works
  9. 9 Contact Dermatitis and Allergies Dermatology 1 works
  10. 10 Glycosylation and Glycoproteins Research Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.1%not open71.9%

World: 40% of research is openly available.

with international co-authors50.9%domestic only49.1%

World: 18% is written across borders.

How has Leo Pharma (Australia)'s research output changed?

Output in 2022-2025 was 23% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Leo Pharma (Australia) as a percentage of every work published that year, 0.00018% in 2024.

still counting0.0010%0.0020%0.0030%Leo Pharma (Australia)0.00014% in 202519801990200020102020

Fractional works of Leo Pharma (Australia) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Brisbane

All research institutions in Brisbane

Share Leo Pharma (Australia)'s ranking

Leo Pharma (Australia) on Science Explorer

A card with Leo Pharma (Australia)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Leo Pharma (Australia). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.